ANVS
Annovis Bio Inc
NYSE: ANVS · HEALTHCARE · BIOTECHNOLOGY
$1.98
+7.34% today
Updated 2026-04-30
Market cap
$60.09M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-1.40
Dividend yield
—
52W range
$1 – $6
Volume
0.8M
WallStSmart proprietary scores
20
out of 100
Grade: F
Strong Sell
Investment rating
4.3
Growth
C6.0
Quality
B3.0
Profitability
D5.0
Valuation
C+3/9
Piotroski F-Score
Weak
—
Altman Z-Score
—
—
Industry rank
—
View all highly rated stocks (75+) →202 stocks currently score above 75
Price targets
Analyst target
$12.50
+532.91%
12-Month target
—
—
Intrinsic (DCF)
—
Margin of safety
—
1 Strong Buy1 Buy0 Hold0 Sell0 Strong Sell
Price chart
X-Ray snapshot
Strengths
Insufficient data
Risks
- Piotroski 3/9 — weak financial health
- Thin margins at 0.00%
- Negative free cash flow $-8.93M
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net income | $-25.15M | $-56.20M | $-24.59M | $-28.85M | $-9.83M |
| EPS | — | — | — | — | $-1.40 |
| Free cash flow | $-17.31M | $-39.97M | $-21.89B | $-25.62B | $-8.93M |
| Profit margin | — | — | — | — | — |
Peer comparison
Smart narrative
Annovis Bio Inc trades at $1.98. Our Smart Value Score of 20/100 indicates the stock is weak. The company scores 3/9 on the Piotroski F-Score.
Frequently asked questions
What is Annovis Bio Inc's stock price?
Annovis Bio Inc (ANVS) trades at $1.98.
Is Annovis Bio Inc overvalued?
Smart Value Score 20/100 (Grade F, Strong Sell).
What is the price target of Annovis Bio Inc (ANVS)?
The analyst target price is $12.50, representing +532.9% upside from the current price of $1.98.
Piotroski F-Score?
3/9 — weak financial health.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNYSE
CurrencyUSD
Quick metrics
P/S ratio—
ROE-220.60%
Beta1.36
50D MA$2.30
200D MA$2.69
Shares out0.03B
Float0.02B
Short ratio—
Avg volume0.8M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—